Roles of stromal cell RANKL, OPG, and M-CSF expression in biphasic TGF-β regulation of osteoclast differentiation

Journal of Cellular Physiology

Volumn 200, Issue 1, 2004, Pages 99-106

  Krast, Mary ^a   Gorny, Genevieve ^a   Sells Galvin, Rachelle J ^b   Oursler, Merry Jo ^a,c,d  

^a UNIVERSITY OF MINNESOTA DULUTH   (United States)

^b ELI LILLY AND COMPANY   (United States)

^c MAYO CLINIC   (United States)

^d MAYO GRADUATE SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COLONY STIMULATING FACTOR 1; COMPLEMENTARY DNA; OSTEOCLAST DIFFERENTIATION FACTOR; OSTEOPROTEGERIN; RNA; TRANSFORMING GROWTH FACTOR BETA; TUBULIN;

ANIMAL CELL; ARTICLE; BONE MARROW CELL; CELL DIFFERENTIATION; GENE EXPRESSION; MOUSE; NONHUMAN; OSTEOCLAST; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; SPLEEN CELL; STROMA CELL;

ANIMALS; BONE MARROW CELLS; CARRIER PROTEINS; CELL DIFFERENTIATION; CELLS, CULTURED; COCULTURE TECHNIQUES; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; GENE EXPRESSION REGULATION; GLYCOPROTEINS; MACROPHAGE COLONY-STIMULATING FACTOR; MEMBRANE GLYCOPROTEINS; MICE; MICE, INBRED BALB C; OSTEOCLASTS; OSTEOPROTEGERIN; RANK LIGAND; RECEPTOR ACTIVATOR OF NUCLEAR FACTOR-KAPPA B; RECEPTORS, CYTOPLASMIC AND NUCLEAR; RECEPTORS, TUMOR NECROSIS FACTOR; SPLEEN; STROMAL CELLS; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA1; TRANSFORMING GROWTH FACTOR BETA2;

EID: 2642584999     PISSN: 00219541     EISSN: None     Source Type: Journal    
DOI: 10.1002/jcp.20036     Document Type: Article

References (34)

1. Fiorelli G, Ballock RT, Wakefield LM, Sporn MB, Gori F, Masi L, Frediani U, Tanini A, Bernabei PA, Brandi ML. 1994. Role for autocrine TGF-beta 1 in regulating differentiation of a human leukemic cell line toward osteoclast-like cells. J Cell Physiol 160(3): 482-490.
2. Fox SW, Haque SJ, Lovibond AC, Chambers TJ. 2003. The possible role of TGF-beta- induced suppressors of cytokine signaling expression in osteoclast/macrophage lineage commitment in vitro. J Immunol 170(7):3679-3687.
3. Gingery A, Bradley E, Shaw A, Oursler MJ. 2003. Phosphatidylinositol 3-kinase coordinately activates the MEK/ERK and AKT/NFkappaB pathways to maintain osteoclast survival. J Cell Biochem 89(1):165-179.
4. Hayashi T, Kaneda T, Toyama Y, Kumegawa M, Hakeda Y. 2002. Regulation of receptor activator of NF-kappa B ligand-induced osteoclastogenesis by endogenous interferon-beta (INF-beta) and suppressors of cytokine signaling (SOCS). The possible counteracting role of SOCSs in IFN-beta-inhibited osteoclast formation. J Biol Chem 277(31):27880-27886.
5. Hughes DE, Wright KR, Mundy GR, Boyce BF. 1994. TGFB1 induces osteoclast apoptosis in vitro. J Bone Miner Res 9(Suppl): SI38.
6. Jennings J, Mohan S, Linkhart T, Widstrom R, Baylink D. 1988. Comparison of the biological actions of TGF-beta-1 and TGF-beta-2: Differential activity of endothelial cells. J Cell Physiol 137:167-172.
7. Khosla S. 2001. Minireview: The OPG/RANKL/RANK system. Endocrinology 142(12):5050-5055.
8. Kodama H, Yamasaki A, Nose M, Niida S, Ohgame Y, Abe M, Kumegawa M, Suda T. 1991. Congenital osteoclast deficiency in osteopetrotic (op/op) mice is cured by injections of macrophage colony-stimulating factor. J Exp Med 173(1):269-272.
9. Laiho M, Keski-Oja J. 1992. Transforming growth factors-beta as regulators of cellular growth and phenotype. Crit Rev Oncog 3(1-2):1-26.
10. Liu J, Tseu I, Wang J, Tanswell K, Post M. 2000. Transforming growth factor beta2, but not beta1 and beta3, is critical for early rat lung branching. Dev Dyn 217(4):343-360.
11. Lyons R, Miller D, Graycar J, Moses H, CDerynck R. 1991. Differential binding of transforming growth factor-β1, -β2, -β3 by fibroblasts and epithelial cells measured by affinity cross-linking of cell surface receptors. Mol Endocrinol 5:1887-1896.
12. Massague J. 1987. The TGF-beta family of growth and differentiation factors. Cell 49(4):437-438.
13. Mundy GR. 1991. The effects of TGF-beta on bone. Ciba Found Symp 157:137-143.
14. Oursler MJ. 1994. Osteoclast synthesis and secretion and activation of latent transforming growth factor beta. J Bone Miner Res 9(4):443-452.
15. Pederson L, Winding B, Foged N, Spelsberg T, Oursler M. 1999. Identification of breast cancer cell line-derived paracrine factors that stimulate osteoclast activity. Cancer Res 59(22):5849-5855.
16. Quinn JM, Itoh K, Udagawa N, Hausler K, Yasuda H, Shima N, Mizuno A, Higashio K, Takahashi N, Suda T, Martin TJ, Gillespie MT. 2001. Transforming growth factor beta affects osteoclast differentiation via direct and indirect actions. J Bone Miner Res 16(10):1787-1794.
17. Roberts AB, Flanders KC, Heine UI, Jakowlew S, Kondaiah P, Kim SJ, Sporn MB. 1990. Transforming growth factor-beta: Multifunctional regulator of differentiation and development. Philos Trans R Soc Lond B Biol Sci 327(1239):145-154.
18. Segarini P, Roberts A, rosen D, Seyedin S. 1988. Membrane binding characteristics of two forms of transforming growth factor-B. J Biol Chem 262:14655-14662.
19. Sells Galvin RJ, Gatlin CL, Horn JW, Fuson TR. 1999. TGF-beta enhances osteoclast differentiation in hematopoietic cell cultures stimulated with RANKL and M-CSF. Biochem Biophys Res Commun 265(1):233-239.
20. Shinar CM, Rodan GA. 1990. Biphasic effects of transforming growth factor-B on the production of osteoclast-like cells in mouse bone marrow cultures: The role of prostaglandins in the generation of these cells. Endocrinology 126:3153-3158.
21. Simonet WS, Lacey DL, Dunstan CR, Kelley M, Chang MS, Luthy R, Nguyen HQ, Wooden S, Bennett L, Boone T, Shimamoto G, DeRose M, Elliott R, Colombero A, Tan HL, Trail G, Sullivan J, Davy E, Bucay N, Renshaw-Gegg L, Hughes TM, Hill D, Pattison W, Campbell P, Boyle WJ, et al. 1997. Osteoprotegerin: A novel secreted protein involved in the regulation of bone density [see comments]. Cell 89(2):309-319.
22. Suda T, Tanaka S, Takahashi N. 1993. Macrophage colon-stimulating factor (M-CSF) is essential for differentiation rather than proliferation of osteoclast progenitors. Osteoporos Int 3(Suppl 1): 111-113.
23. Suda T, Kobayashi K, Jimi E, Udagawa N, Takahashi N. 2001. The molecular basis of osteoclast differentiation and activation. Novartis Found Symp 232:235-247; Discussion 247-250.
24. Takahashi N, Udagawa N, Akatsu T, Tanaka H, Isogai Y, Suda T. 1991. Deficiency of osteoclasts in osteopetrotic mice is due to a defect in the local microenvironment provided by osteoblastic cells. Endocrinology 128(4):1792-1796.
25. Takahashi S, Reddy SV, Dallas M, Devlin R, Chou JY, Roodman GD. 1995. Development and characterization of a human marrow stromal cell line that enhances osteoclast-like cell formation. Endocrinology 136:1441-1449.
26. Takai H, Kanematsu M, Yano K, Tsuda E, Higashio K, Ikeda K, Watanabe K, Yamada Y. 1998. Transforming growth factor-beta stimulates the production of osteoprotegerin/osteoclastogenesis inhibitory factor by bone marrow stromal cells. J Biol Chem 273(42):27091-27096.
27. ten Dijke p, Iwata K, Goddard C, Pieler D, Canalis E, McCarthy T. 1990. Recombinant transforming growth factor type β: Biological activities and receptor-binding properties in isolated bone cells. Mol Cell Biol 10:4473-4479.
28. Theill LE, Boyle WJ, Penninger JM. 2002. RANK-L and RANK: T cells, bone loss, and mammalian evolution. Annu Rev Immunol 20:795-823.
29. Thirunavukkarasu K, Miles RR, Halladay DL, Yang X, Galvin RJ, Chandrasekhar S, Martin TJ, Onyia JE. 2001. Stimulation of osteoprotegerin (OPG) gene expression by transforming growth factor-beta (TGF-beta). Mapping of the OPG promoter region that mediates TGF-beta effects. J Biol Chem 276(39):36241-36250.
30. Udagawa N, Takahashi N, Akatsu T, Tanaka H, Sasaki T, Nishihara T, Koga T, Martin TJ, Suda T. 1990. Origin of osteoclasts: Mature monocytes and macrophages are capable of differentiating into osteoclasts under a suitable microenvironment prepared by bonemarrow-derived stromal cells. Proc Natl Acad Sci USA 87(18):7260-7264.
31. Wesolowski G, Duong LT, Lakkakorpu PT, Nagy RM, Tezuka K-I, Tanaka H, Rodan GA, Rodan SB. 1995. Isolation and characterization of highly enriched, prefusion mouse osteoclastic cells. Experimental Cell Res 219:679-686.
32. Yamaguchi M, Kishi S. 1995. Differential effects of transforming growth factor-beta on osteoclast-like cell formation in mouse marrow culture: Relation to the effect of zinc-chelating dipeptides. Peptides 16:1483-1488.
33. Yoshida H, Hayashi S, Kunisada T, Ogawa M, Nishikawa S, Okamura H, Sudo T, Shultz LD. 1990. The murine mutation osteopetrosis is in the coding region of the macrophage colony stimulating factor gene. Nature 345(6274):442-444.
34. Zheng MH, Fan Y, Wysocki SJ, Lau AT, Robertson T, Beilharz M, Wood DJ, Papadimitriou JM. 1994. Gene expression of transforming growth factor-beta 1 and its type II receptor in giant cell tumors of bone. Possible involvement in osteoclast-like cell migration. Am J Pathol 145(5):1095-1104.